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Introduction
Cardiovascular disease (CVD) is the name of a larger construct, 
which involves diseases of the heart, brain vasculature and blood 
vessels1. Several data indicate that CVD is the major cause of dis-
ability and death worldwide1,2. To date, CVD seems to be responsible 
for 30% of the annual deaths in low and middle income countries2. 
Projections for the next years do not indicate a better scenario, 
since is expected that this number will increase exponentially2.
Among the variety of CVD risk factors, physical inactivity 
is highlighted as a phenomenon strongly associated with CVD 
development, regardless of body mass index2. The effects of 
physical activity (PA) (e.g., walking, climbing stairs) on CVD 
risk factors are widely known, which explains its popularity with 
healthy individuals who want to avoid CVD2. In turn, physical 
exercise (PE), which concerns planned and structured body 
movement aimed to improve one or more physical capacities, 
has been widely suggested as a powerful non-pharmacological 
tool by different international associations, in order to prevent and 
counteract the deleterious effects of CVD in the organic system, 
due its capacity to offer larger effects in comparison with PA2,3,4,5,6.
In fact, several studies, including systematic reviews and 
meta-analytic data, indicate that PE is capable of leading to 
changes in the pathophysiological course of different CVD, 
such as hypertension (HTN), coronary artery disease/myocardial 
infarction (MI) and heart failure (HF)7,8,9,10. Although the clinical 
effects of PE on the different CVD are already known, the mecha-
nisms associated with such changes must still be elucidated.
It is widely acknowledged that experiments with humans 
have limited capacity to contribute to the investigation of the 
mechanisms associated with the effects of PE on CVD and, 
usually, inferences are limited to systemic analyses (i.e., plasma 
and/or serum).
In this sense, studies using animal models have emerged as 
an effective tool to explore the several mechanisms triggered 
by PE in different organs and tissues, as well as in the whole 
organic system. Regarding animal models in the CVD context, 
experiments have been performed with different types of animals, 
including species that spontaneously developed the disease due to 
genetic factors and animals that underwent surgical procedures.
In fact, HTN, for example, is commonly studied in 
Spontaneous Hypertensive Rats (SHR), since the pathogenesis 
of HTN in this species is multifactorial, as in humans. However, 
if necessary, researches can also study HTN triggered by specific 
alterations in the renal system (i.e., one kidney one clip [1K1C], 
two kidneys one clip [2K1C] and two kidneys two clip [2K2C]), 
using pharmacological approaches (i.e., L-NAME [Nω – nitro-
L-arginine methyl ester], DOCA [deoxycorticosterone acetate]) 
and associated with diseases, such as obesity, and physiologi-
cal conditions, such as menopause (i.e., ovariectomized), for 
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example. Moreover, such possibilities are not exclusively related 
to HTN, and several possibilities are available in the context 
of MI (e.g., Left anterior descending coronary artery ligation 
[CAL], Ischemia-Reperfusion model [IRM] and MI-induced by 
isoproterenol) and HF (e.g., hyperadrenergic activity, CAL, doxo-
rubicin, left coronary artery microembolization  with polystyrene).
The mechanisms responsible for the beneficial effects of 
PE on CVD have been studied in some of the aforementioned 
models, and much has been discovered. To contribute with this 
Special Issue, denominated: Animal Studies: Contributions to 
Exercise Physiology, we aimed to provide a brief description 
of the mechanisms and clinical aspects observed in the animal 
models that are most used to study the effects of PE on CVD.
This knowledge is important not only for undergraduate stu-
dents, but also for graduate and post-graduate students, as well 
as for researches that require an overview of the main animal 
models used in the context of PE and CVD.
 Hypertension
HTN is one of the most prevalent diseases in adult life11. In older 
people, for example, the prevalence of HTN is elevated, reaching 
values above 60% in both sexes11,12. The main concern about this 
disease is its poor prognosis because patients with high blood 
pressure (BP) show increased risk for stroke (i.e., hemorrhagic 
and ischemic) and MI11,12. Moreover, a recent report from the 
World Health Organization (WHO) established HTN as the
main risk factor for death worldwide11,12.
SHR have been widely used in scientific experiments, mainly 
because it is considered analogous with essential HTN in human by 
several authors13,14,15,16,17. This animal model of HTN was created 
by mating Wistar rats that showed the highest BP levels. After 20 
generations, the animals began to develop spontaneous HTN in 
early adulthood13. In these animals, BP increases exponentially 
with aging, which occur mainly due to elevated vascular peripheral 
resistance (VPR) rather than to modified cardiac output (CO)15,18.
As in humans, the pathogenesis of HTN in SHR seems to 
be multifactorial, since these animals show morphological and 
functional alterations on the different physiological elements 
that compose BP control, such as heart, kidney, blood vessels 
and autonomic control. Interestingly, these alterations have dis-
similar time-courses, and factors associated with elevated BP 
in SHR are observed from the first weeks of life.
Data are inconclusive about HTN condition in young SHR 
(ySHR) (~4 weeks old), once during this age the animals present 
a high oscillation in BP values (as demonstrated by data using 
direct and indirect measurements) with some evidence indicat-
ing HTN19,20 — BP values next to 150 mmHg — and others 
not21,22. Therefore, during this time of life animals are generally 
denominated as pre-hypertensive. However, a significant number 
of evidence have been indicating that, even in the absence of 
alterations on BP measurements, morphological alterations on 
different vascular beds of the cardiovascular system and in the 
kidney, are observed in ySHR21,22,23,24.
In the kidney, for example, increased cross-sectional area 
(CSA) of the intima and adventitia layer, concomitantly with 
increased wall lumen, are found in the renal arteries of ySHR in 
comparison with age-matched normotensive control23. Data are 
also observed in other vascular beds (i.e., aorta, mesenteric), and 
evidence indicate elevated intima (IT), media (MT) wall thick-
ness (WT), media-lumen ratio (M/L), media cross-sectional area 
(MCSA) and hypertrophy of smooth muscle cells in ySHR21,22,24,25. 
Such alterations increase linearly and progressively with aging, 
and results of modified vascular structure in 8-week and 12-week 
old SHR (adult SHR [aSHR]) are larger than in ySHR and age-
matched WKY control22. In this sense, results from analyses in the 
kidney of aSHR demonstrated increased indications of renal injury 
and abnormalities in comparison with normotensive animals26.
Nevertheless, experiments in the thoracic aorta of aSHR 
identified elevated mRNA expression of α-actin (+9-fold), 
elastin (+6-fold) and collagen I and III (+11-fold) in comparison 
with normotensives27. Moreover, as observed in ySHR, the 
content of connective tissue, elastic fibers, and fibrils, as well 
as the CSA, were higher in the aorta of aSHR in comparison 
with  age- matched  control 27.
Regarding functional alterations, aSHR show an endothelium 
phenotypic profile close to what is generally observed in endothelial 
dysfunction, characterized by increased reactive oxygen species 
(ROS) synthesis, oxidative stress activity and decreased antioxidant 
activity, culminating in a substantial impairment on endothelium-
dependent dilation28,29,30. In fact, endothelium-dependent dilation is 
decreased in the vessels of aSHR in comparison with WKY28,29,30. 
Participation of the endothelium in this phenomenon seems to 
be clear when pre-treatment with L-Nitro-Arginine Methyl Ester 
(L-NAME) — a nitric oxide (NO) inhibitor — abolishes differ-
ences between normotensive and hypertensive animals30.
Noteworthy, NO is a molecule synthesized by the vascular 
endothelium is response to several stimuli (e.g., shear stress, acetyl-
choline [ACh]) and it is the main action that occurs in the smooth 
muscle cells, causing vasodilation by altering calcium kinetics, 
through activation of soluble guanylate cyclase (sGC)/ cyclic 
guanosine monophosphate (cGMP) (sGC/cGMP) pathway31,32. 
Moreover, this free radical seems to be important to mediate the 
effects of other vasodilatory molecules, such as angiotensin (ANG) 
(1-7)33,34. Interestingly, vasodilatory response to ANG (1-7) is 
decreased in the aorta of aSHR, and impairment on NO pathway 
activity is a possible hypothesis to explain this phenomenon29.
As aforementioned, increased oxidative stress activity is 
generally observed during endothelial dysfunction. In aSHR, this 
phenomenon is not observed only in the heart, lung and kidney 
— organs associated with cardiovascular control — but also in 
the aorta and erythrocytes35,36. On the other hand, superoxide 
dismutase (SOD), catalase (CAT) and glutathione peroxidase 
(GPx) — antioxidant enzymes that contribute to the control of 
oxidative stress —, as well as the total antioxidant activity, are 
found decreased35,36.
Oxidative stress decreases NO mainly due to anion superoxide 
(O2-) actions37,38,39,40,41. After superoxide anion (O2-) synthesis, 
by uncoupled endothelial NO synthase (eNOS), NAD(P)H 
oxidase and mitochondria, this molecule reacts quickly with 
NO, creating peroxynitrite (ONOO-)37,38,39,40,41, which, in turn, 
reacts with cellular elements that act in NO synthesis, such as 
tetrahydrobiopterin (BH4), a precursor of NO37,38,40. Therefore, 
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it is possible to observe that decrease in NO bioavailability 
is a retro-pathway, which, if not stopped, can cause serious 
damages to the homeostasis of the organic system, mainly on 
endothelial function.
One interesting issue about SHR animals concerns the asso-
ciation between autonomic control and vascular function. In the 
mesenteric vessels, for example, ySHR show higher sensitivity 
to noradrenaline (NA), demonstrated by early vasoconstrictor 
response, than WKY rats, which is associated with higher influx 
of calcium and lower baroreflex sensitivity (gain) (BrS)22,42,43.
This phenomenon is exacerbated by age, since aSHR dem-
onstrate not only higher sensibility to NA infusion and electrical 
stimulus, but also decreased vasodilator response after ACh 
infusion in mesenteric and carotid vessels22,23,43,44,45, as well as 
BrS in conscious and nonconscious rats47,48,49. Furthermore, 
evidence have been found that morphological and functional 
alterations on blood vessels, such as arterial stiffness, decreased 
endothelium-dependent dilation, and oxidative stress are associ-
ated with BrS impairment35. Thus, data indicate that vascular 
and morphological alterations in blood vessels are associated 
with cardiac autonomic control.
In this regard, aSHR showed increased cardiac and periph-
eral sympathetic activity19,26,44,47,48 and blocked of α1-receptor 
with prazosin inhibit in ~95% of the vasoconstrictor response 
to electrical stimulation, causing absence of differences in 
relation to the response of control animals23. Several evidence 
have showed that aSHR presents reduced heart rate variability 
(HRV) and increased systolic AP variability (SAP), followed 
by alterations in analyses of the frequency domain, indicating 
alteration in the sympathovagal balance26. Moreover, this phe-
nomenon is not just an effect of increased sympathetic activity 
discharge from the central nervous system to the periphery, but 
an environmental complex proving vasoconstrictor response.
This idea seems to be clear in the experiment of Reja et al. 
(2002)49, who observed elevated α1A-receptor (α1A-R), concomi-
tantly with decreased α2A-receptor (α2A-R), gene expression levels 
on neural system — central (i.e., ventromedial hypothalamus 
[VHM] and rostral ventrolateral medulla oblongata [RVLM]) 
and peripheral (i.e., spinal cord) — and on peripheral organs 
associated with BP control, as myocardium and adrenal medulla 
tissue studying aSHR 50. Furthermore, this overexpression of 
α1A-R on the central and peripheral nervous system and on the 
peripheral organs are positively correlated with BP in SHR49.
Yet, administration of phenoxybenzamine — a α-adrenergic 
receptor blocker — causes significant decrease on BP and HR in a 
dose-dependent manner in comparison with normotensive control 
rats50. High drug levels caused total absence of differences of the 
aforementioned parameters between aSHR and control groups50. 
Authors also tested the effects of β-adrenergic receptor blocker, 
propranolol, in cardiovascular parameters. Results indicate that 
inhibition of β-adrenergic receptor leads to significant decrease 
on HR in aSHR to levels similar to control group50.
Additionally to the morphological and functional alterations 
in the vascular endothelium, in organs associated with BP control 
(e.g., heart, kidney), and in the autonomic control of the cardio-
vascular system, an upregulation of some molecular pathways 
in the brain areas responsible for BP control are found in SHR.
As in the peripheral tissues, brain renin-angiotensin system 
(RAS) acts regulating cardiovascular control51,52. Importantly, 
during HTN the blood-brain barrier (BBB) is markedly disrupted 
in areas associated with autonomic cardiac control — such as 
RVLM, nucleus tractus solitarius (NTS) and paraventricular 
nucleus (PVN) —, which allows for extravasation of peripheral 
ANGII to these areas, as demonstrated trough infusion of fluo-
rescently labeled ANGII in SHR117,118. Therefore, it is possible 
that elevated ANGII in the brain is, partially, explained by the 
peripheral activity of RAS117,118.
Regarding the pathway, in summary, after the cleavage of 
renin by the substrate angiotensinogen (Aogen), the decapeptide 
angiotensin I (ANG I) will be formed51,52. From the activity of 
the angiotensin-converting enzyme (ACE), ANG I is cleaved 
in an octapeptide, called angiotensin II (ANG II), which seems 
to be the neuropeptide responsible for RAS negative effects on 
cardiovascular control through its binding with AT1R
51,52.
Seminal data demonstrated that inhibition of the activity of 
RAS components in the brain by direct ventricular infusion of 
saralasin — a ANGII antagonist —, or even by antisense treatment, 
with consequently impair AT1R and Aogen, leads to decrease on 
BP values of aSHR in a dose-dependent manner16,53. Recent studies 
have confirmed these evidences, showing that the expression of 
RAS components, as ACE, AT1R, Aogen, are increased in brain 
areas responsible for cardiovascular control (e.g., RVLM, NTS), 
which, in turn, is associated with BP values34,54.
Interestingly, BP modulation by RAS does not seem to occur 
alone, but in conjunction with the activity of ROS and inflam-
matory elements, such as proinflammatory cytokines, adhesion 
molecules, and transcription factors (nuclear factor-κB [NFκB])55. 
In fact, blockade of NFκB in the PVN leads to lowering of mean 
BP, as well as decreased mRNA expression of proinflammatory 
cytokines, such as tumor necrosis factor-α (TNF – α), interleukin-
1β (IL-1β) and IL-6 (IL-6), and ROS (e.g., O2
-,ONOO-)56. In ad-
dition, analysis of data from experiments on aSHR indicate that 
ROS and proinflammatory elements are elevated in similar brain 
areas, and times, supporting the idea of an integrated complex of 
cardiac control between these pathways in SHR34,47,48,54.
After elevation of ROS by RAS, O2
 – and other ROS can 
lead to phosphorylation of the extracellular signal–regulated 
kinases ½ ( ERK ½), — a signaling protein kinase — which 
promptly activates NFκB trough the inhibition of Iκβα, an 
inhibitory anchoring protein, allowing the translocation 
of NFκB to nucleus, increasing the synthesis of ROS and 
PICs39,47,57. In aSHR, mRNA expression of NAD(P)H oxidase 
and the activity of ROS are elevated in the PVN, followed by 
elevated phosphorylation of ERK ½ and IKKβ, in addition to 
NFκB binding to the DNA33,58. Moreover, data demonstrated 
that increased ROS, ERK ½ and NFκB activity is associated 
with increased levels of PICs, as well as decreased levels of 
anti-inflammatory cytokines (i.e., interleukin-10 [IL-10]) in 
aSHR33. Considered together, these data indicate that, in the 
brain of aSHR, a molecular complex formed by RAS, ROS 
and PICs acts on cardiovascular control.
Regarding the mechanisms responsible for increased BP 
observed in aSHR, downstream of ROS and proinflamma-
tory cytokine activity lead to alteration in autonomic cardiac 
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control59,60. In the experiment of Takagishi et al.60, for example, 
exogenous IL-6 administrated by microinjection in the NTS 
causes ~35% inhibition of baroreceptor bradycardia reflex gain 
in a dose-dependent manner60.
Moreover — despite the exacerbation of activity of hyper-
tensive elements in the brain areas of SHR — some pathways, 
such as ANG 1-7/Mas receptor and anti-inflammatory cytokines 
(i.e., IL-10), that could act as counter-regulatory agents, con-
sequently decreasing BP values, show lower expression in the 
brain of aSHR in comparison with normotensive age-matched 
control33,34. ANG (1-7), for example, is formed by the cleavage 
of ANG II by ACE 2 and, in the brain areas of cardiovascular 
control, acts through Mas receptors in the tonic and reflex control 
of BP52,61. Yet, evidence indicates that ANG (1-7) control of BP 
can occur due to its influence on BrS52,61.
The effects and mechanisms of PE on hypertension: 
evidences from SHR
PE is considered a beneficial non-pharmacological therapy to 
induce decrease on BP values in hypertensive patients, being 
considered one of the most important changes in lifestyle of 
these patients3,62. Several evidence indicate that aerobic PE is an 
effective stimulus to induce acute (hypotension post-exercise) and 
chronic decrease on BP values in humans3,63,64,65. Nevertheless, 
recent reviews (i.e., descriptive and meta-analyses) have described 
the potential of resistance training to contribute to this control58,66.
Experiments have demonstrated lower BP values in trained 
aSHR in comparison with sedentary aSHR after treadmill, 
swimming and resistance exercise26,33,34,47,48,54,67. A recent meta-
analysis, which analyzed 17 studies in SHR, confirmed these 
data and demonstrated that PE is capable of leading to significant 
decrease on BP values17.
Morphological and functional alterations on organs associ-
ated with BP control (e.g., heart, kidney) and on blood vessels 
are one of the most evident alterations triggered by PE in aSHR. 
In the aorta, for example, low to moderate aerobic physical 
training performed 5 days per week, one hour per day, over 
three months caused decrease on smooth cells volume, elastic 
components and connective tissue in the aorta27. These effects 
are followed by significant decrease in the mRNA expression 
of α-actin, elastin, and collagen I and III27. Results were not dif-
ferent in the heart since collagen content and cardiac load were 
decreased, and myocardial performance index (MPI) and left 
ventricular chamber diameter were increased in aSHR submitted 
to moderate aerobic exercise during 10 weeks68. Yet, swimming 
exercise decreased the number of sclerosis glomerular index in 
the kidney of SHR26.
Morphological alterations are generally followed by functional 
changes caused by oxidative stress and characterized by decreased 
endothelium-dependent dilation. PE seems to be an efficient 
stimulus to counter-regulate this phenotype. In fact, after PE, the 
total antioxidant activity was increased in the heart, kidney, aorta, 
and erythrocytes of aSHR35,36. Concomitantly, total oxidant activity 
was decreased in the lung, as well as lipid peroxidation (LPO) in 
the aorta35,36. Such alterations on pro and antioxidant molecules 
seem to be sensible, and after 10 weeks of detraining total oxidant 
activity is again increased in the kidney  and in the liver36.
Functionally, PE improves ACh-mediated vasodilation and 
flow-mediated dilation in aSHR, restoring endothelial function 
in hypertensive animals28,30. PE also increases the vasodilator 
response to ANG (1-7) and improves the expression of Mas 
receptor in the aorta29. Interestingly, this response seems to be 
endothelium-dependent, since in endothelium-denuded vessels 
from trained SHR the vasodilator effect induced by ANG (1- 7) 
was abolished. Moreover, NO and Mas receptor inhibition 
impairs the effects of PE29.
Improvements on autonomic cardiac control have been 
extensively studied and suggested as one of the main benefits 
in response to PE in hypertensive patients. In turn, use of SHR 
models have contributed to a better understanding of this phe-
nomenon and Krieger et al.69 already indicated this change as 
one of the main physiological adaptations in response to PE.
As in humans, several evidence using different types of exer-
cise (i.e., treadmill running, swimming) have indicated that PE 
is capable of improving HRV and SAPV, which is accompanied 
by improvement in sympathovagal balance in aSHR26,47,48,68. 
Furthermore, authors reported that the aforementioned changes 
are associated with total restore of BrS and vagal tonus, as well 
as sympathoinhibiton26,47,48. Regarding BrS, the effects of PE 
have been cited since the late 1990s69. In a seminal experiment, 
for example, Brum et al.70 observed that after 13 weeks of low-
intensity aerobic PE the AP range for triggering baroreceptor 
activation and the relation between the baroreflex discharge 
and changes on SAP of aSHR were increased in comparison 
with  sedentary animals70.
Interestingly, changes in cardiac and peripheral autonomic 
control after PE seem to occur through the afferent baroreceptor 
modulation68. In fact, experiments have indicated that aSHR 
submitted to sinoaortic denervation presented no alteration on 
BrS, HRV and SAP after PE protocol68.
Results from experiments on aSHR have contributed to 
understanding the effects of PE on the expression and activ-
ity of hypertensive elements in the brain areas responsible for 
cardiovascular control. Nevertheless, evidence were not limited 
to this specific issue, also demonstrating a possible correlation 
with cardiovascular function.
In fact, data demonstrate that low to moderate and moderate 
PE can cause significant decrease on RAS in the brain areas 
responsible for cardiovascular control of SHR. Data indicate 
lower mRNA expression of Aogen, ACE and AT1R in the NTS 
and RVLM of trained aSHR in comparison with sedentary 
aSHR34,54. On the other hand, ANG (1-7) pathway components 
(i.e., ACE2 and Mas receptor) showed elevated expression in 
the RVLM after exercise34. Similarly, ROS generation, NAD(P)
H subunits (i.e., p47phox, gp91phox) activity, phosphorylated 
ERK ½ and IKKβ, NFκB translocation and proinflammatory 
cytokines synthesis (i.e., IL-6 and TNF-α) were lower in the 
PVN, RVLM of aSHR33,34,47,48. Noteworthy, such alterations 
on gene expression and activity seem to be correlated with 
cardiovascular control since decrease on RAS components and 
proinflammatory cytokines are correlated with improved BrS 
and AP decrease47,54.
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In an interesting experiment, Masson et al.47 described the 
time-course changes in the expression of the aforementioned 
pathways in the PVN of aSHR47. During 8 weeks, animals were 
submitted to low-to-moderate intensity PE, which occurred 5 
days per week, 1 hour per day. To evaluate the time-course, 
evaluations occurred before the start and during the 1st, 2nd, 
4th and 8th weeks of the PE program. Results showed that PE 
was capable of causing significant decrease on ROS, ERK1/2 
phosphorylation, NFκB translocation and proinflammatory 
cytokines synthesis in the first two weeks of exercise47. These 
results remained during the next weeks of training and were 
accompanied by an increase on autonomic cardiac control47.
In addition, experiments have demonstrated that PE can 
change the pattern of neurotransmitters release in PVN, as 
demonstrated by Jia et al.33, who submitted aSHR to 16 weeks 
of moderate-intensity aerobic exercise (60% of maximal aero-
bic velocity, 5 days per week, 60 min per day). After exercise, 
authors observed lower levels of excitatory neurotransmitters 
— glutamate and NA — and high levels of inhibitory neurotrans-
mitters  — GABA — in the PVN of SHR33.
Table 1 shows a summary of the pathophysiological elements 
present in SHR, as well as the effects of PE.
Table 1. Physiopathological characteristics observed in SHR and the 
effects of PE
Physiopathological characteristics Effects of PE
Hemodynamic
↑ Blood pressure ↓
Vascular
↑ Adventitia CSA ↓
↑ Media CSA ↓
↑ Intima CSA ↓
Hypertrophy of smooth cells ↓




↓ Antioxidant activity ↑
↓ endothelium-dependent dilation ↑
Cardiovascular autonomic control
↑ Cardiac sympathetic activity ↓
↑ Perypheral sympathetic activity ↓
Central Nervous System
↑ RAS activity ↓
↑ Oxidative stress ↓
↑ PICs ↓
CSA: Cross-sectional area; PE: Physical exercise; PICs: Proinflammatory 
cytokines; SHR: Spontaneuos hypertensive rats; RAS: Renin-angiotensin 
system; ROS: Reactive oxygen species.
Myocardial infarction
As aforementioned, CVDs are the leading cause of mortality 
worldwide1. Among them, coronary artery disease (CAD) stands 
out due to its high risk of death11.
CAD has, as the main characteristic, the formation of ath-
erosclerotic plaque in medium and large arteries. In summary, 
atherosclerotic plaque starts to build up due to endothelial 
dysfunction, which increases the permeability of the arterial 
intima layer to plasma lipoproteins — such as low-density 
lipoprotein (LDL), favoring the retention of such elements in 
the subendothelial space, when, later, in association with in-
flammatory markers (e.g., macrophages), the lipoproteins will 
undergo oxidation, forming the oxidized LDL (oxLDL)71. This 
phenomenon is followed by a myriad of inflammatory events, 
which have the formation of foam cells through phagocytosis 
of oxLDL by macrophages as the final event of the pathway71. 
It should be noted that the formation of oxLDL is associated 
with the quantum of available LDL in the plasma. Therefore, 
a higher number of LDL in the plasma will lead to increased 
formation of oxLDL and, consequently, of foam cells71.
Once developed, atherosclerotic plaque is composed of a 
cholesterol-rich lipid and a collagen-rich fibrous cap. The lipid 
content of the atherosclerotic plaque is the element responsible 
for its integrity, since disruption of this structure leads to forma-
tion of thrombus, which, if in contact with coronary circulation, 
can impair myocardial blood flow, thus causing ischemia and, 
possibly, MI71. Therefore, MI is defined as myocardial cell death 
due to prolonged ischemia72.
Studies using animal models are conducted to provide better 
understanding concerning the effects of PE pre and post MI. The 
most widely used protocol of MI in animals, mainly rodents, 
is occlusion of left anterior coronary artery. The MI surgery is 
conducted with the rat anesthetized with ketamine (80mg/kg) 
and xylazine (12mg/kg). After intubation, animals are positive-
pressure ventilated with room air at 2.5mL, 65 strokes/minute 
with a pressure-cycled rodent ventilator. To induce MI, a 2-cm 
left lateral thoracotomy is performed in the third intercostal 
space, and the left anterior descending coronary artery is oc-
cluded with a nylon (6.0) suture at approximately 1 mm from its 
origin below the tip of the left atrium. It is important to mention 
that studies generally use a sham group, which is also submitted 
to the same procedures, except for myocardial ischemia, which 
was not induced in this case73,74.
Following myocardial ischemia, it is possible to observe a 
substantial myocardial tissue loss, resulting in increased cardiac 
load that, in turn, induces ventricular remodeling of the infarcted 
border zone and the remote non-infarcted myocardium. Myocyte 
apoptosis, necrosis, and the resultant increased hemodynamic 
load activate multiple biochemical intracellular signaling that 
triggers left ventricular (LV) dilatation, hypertrophy, ventricular 
structure distortion, and collagen scar formations. Progression 
of MI observed in rats shows a similar pattern compared to that 
observed in human beings, since they have an altered survive 
rate and, after four weeks, present a phenotypic condition ob-
served in HF75.
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The effects and mechanisms of PE on MI: evidence from 
the surgical MI model
PE is a non-pharmacological therapy widely recommended for 
CVD patients, which has been demonstrated to be effective in 
improving endothelial function76, BrS, autonomic function77, 
as well as reducing tissue and systemic inflammatory state78.
Such improvements can be identified in human beings with 
tools already validated. Moreover, these evaluations are relatively 
easy and non-invasive if performed by an experienced evaluator, 
since, sometimes, just blood is necessary. However, in order to 
thoroughly evaluate the molecular, cellular and physiological 
mechanisms involved in these improvements, experimental 
models are necessary.
In fact, guidelines for rehabilitation programs in MI pa-
tients recommend that low-intensity PE starts approximately 1 
month after MI5. However, animal studies have shown that if 
PE starts as soon as possible after MI this can further improve 
heart function, increasing maximum stroke volume, ejection 
fraction and attenuating the deterioration of LV contractility. 
These beneficial effects may be associated with PE-induced 
proliferation of cardiomyocytes, angiogenesis, attenuation of 
apoptosis in cardiomyocytes, due to improvement of myofila-
ments and management of intracellular calcium (Ca2+)79.
It is known that — during and after MI — neurohumoral 
changes occur in order to minimize the consequences of re-
duced ventricular function and, consequently, cardiac output. 
On the other hand, chronically, autonomic imbalance is usually 
followed by abnormalities in cardiorespiratory reflex control, 
leading to impairment of BrS and function, and increased acti-
vation of ergoreflex and chemoreflex. In turn, evidence shows 
that PE allows for the improvement of autonomic function and 
subsequent reduction of mortality in humans77.
In this sense, in order to identify the mechanisms associated 
with improvement in autonomic function after PE in MI, Jorge 
et al.80 tested the effects of early aerobic exercise training on LV 
and autonomic function, hemodynamics, tissue blood flow, and 
mortality rate after MI in rats. Results from PE demonstrated 
that the intervention induced improvement of cardiac function 
(i.e., systolic and diastolic), followed by normalization of he-
modynamic and regional blood flow, as well as improvement of 
autonomic control of peripheral circulation (i.e., BrS and increase 
on pulse interval [PI]) and cardiac function. Furthermore, the 
authors observed increased SERCA2 and VEGF mRNA ex-
pression in LV. However, these benefits resulted in significant 
reduction in mortality rate in trained animals. According to the 
authors, the fact that early training restored autonomic control 
of circulation – represented by BrS and HRV – suggests that 
training may not only increase reflex responses mediated by the 
parasympathetic nervous system, but also suppress the influence 
of the sympathetic nervous system on ischemic heart disease. 
Moreover, elevated SERCA2 and VEGF mRNA expression 
suggests that these improvements are associated with alterations 
in intracellular calcium handling and blood supply.
Nerve growth factor (NGF) inducing cardiac sympathetic 
nerve sprouting is another characteristic observed post-MI. This 
phenomenon causes substantial sustained increase in sympathetic 
activity, resulting in downregulation and desensitization of β1 
and β2-adrenergic receptor (β1-AR and β2-AR, respectively), 
and in upregulation of β3-AR.
On the other hand, Chen et al.79, assuming that several evi-
dences indicate that PE decreases sympathetic activity after MI, 
investigated whether such phenomenon occurred by inhibition of 
sympathetic nerve sprouting and restoring of β3-AR/β1-AR ratio.
Results from the aforementioned study showed that PE in-
hibits cardiac sympathetic nerve sprouting and restores β3-AR/
β1-AR balance after MI; which seems to occur due to increase 
in mRNA expression of β3-AR. Moreover, authors observed 
increased activation of NO synthase 1 (NOS1) and NOS2 in the 
heart of animals submitted to PE, indicating possible modulation 
of β3-AR through NO pathway. Therefore, considered together, 
these results indicate that the protective effect of PE in MI can 
be modulated by β3-AR/NO pathway79.
In fact, it is known that after MI, β3-AR is upregulated and 
activated due to high availability of NA. Dissimilar from the 
other β-receptor subunits, β3 seems to play a protective role after 
MI, acting as a counterregulatory mechanism during sympathetic 
overstimulation. Activation of β3-AR induces NO production, 
which, in turn, is associated with NOS1 activity. NOS1 signaling 
leads to increased cardiac calcium cycling, followed by enhanced 
cardiac contraction and accelerated relaxation79.
Thus, the authors suggested that the beneficial effects of 
β3-AR stimulation after PE are associated with the activation 
of NOS2 and NOS1, and the normalization of β-AR balance.
Regarding menopause, its main characteristic is the loss of 
the cardioprotective effects of estrogen, including on autonomic 
function. In this sense, Flores et al.81 investigated the effects 
of PE in MI-rats with ovarian hormone deprivation. Results 
demonstrated PE-induced improvement in cardiopulmonary 
BrS, which was correlated with improvement in the autonomic 
control, represented by increased vagal tone in trained animals.
These data are confirmed by Rondon et al.82, who observed 
that the improvement in BrS induced by exercise training in 
infarcted rats is due, in part, to increased aortic depressor nerve 
activity, concomitantly with improving cardiac vagal modulation.
Studies have not been exclusively developed in order to 
verify the effects of PE after MI, but also its cardioprotective 
effects. In the experiment of Bozi et al.83 and Rodrigues et 
al.74, for example, the authors conducted a study in which rats 
performed aerobic exercise training for 8 weeks prior to MI 
surgery. After MI event, trained rats showed a smaller infarct 
extension and sympathetic activity, as well as increased BrS, 
and parasympathetic modulation compared with sedentary in-
farcted animals. Additionally, Rodrigues et al.74 observed that 
improvements in autonomic balance and in parasympathetic 
modulation were strongly correlated with structural, systolic, 
diastolic and global LV function.
A recent study aimed to explore the effects of prior PE on 
the inflammatory aspects associated with MI. In fact, Santos et 
al.84 evaluated rats exercised prior MI and observed that exercise 
training modulated proinflammatory cytokines response triggered 
by MI. Furthermore, exercise group showed increased PPAR-α. 
This molecule is a ligand-activated transcription factor that 
modulates the activity of genes involved in energy metabolism 
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regulation and inflammatory processes, acting as a suppressor 
of the inflammatory state.
In the control group, negative correlation between TNF-α and 
NF-κB was observed. However, these results were not observed 
in the trained group, which seems to be mediated by PPAR-α 
activation. Therefore, these data demonstrated that previously 
exercised animals had lower levels of local inflammatory mark-
ers and less myocardial apoptosis, which seemed to be related 
to the presence of PPAR-α.
It is important to mention that due to significant functional 
loss in MI patients, mainly due to exacerbated muscle atrophy, 
resistance exercise was recommended as a complementary type 
of PE in relation to aerobic exercise. In this sense, Grans et al.116 
evaluated the effects of dynamic resistance training on cardiac 
and hemodynamic function, as well as cardiovascular autonomic 
control after MI in rats. Results demonstrated that resistance 
exercise did not improve cardiac function. On the other hand, 
PE improved exercise tolerance and prevented additional loss 
in cardiovascular autonomic modulation.
Interestingly, Barboza et al.85 conducted one of the few stud-
ies that aimed to understand the effects of detraining on cardiac 
function, BrS, and mortality rate. To this end, MI rats were sub-
mitted to PE for 3 months with subsequent 1 month of detraining. 
The authors observed that PE reduced the infarcted area, concomi-
tantly with improvement on systolic and diastolic functions, on BrS 
and reduction on mortality rate. Moreover, the detraining period was 
not enough to reverse the beneficial outcomes resulting from PE.
Table 2 presents a summary of the physiopathological ele-
ments present in MI rats, as well as the effects of PE.
Table 2. Physiopathological characteristics observed after MI in rats 
and the effects of PE
Physiopathological characteristics Effects of PE
Heart morphology and function
↑ Akinetic LV area ↓
↑ LV mass ↓
↓ EF shortening ↓
Cardiovascular autonomic control
↓ BrS ↑
↓ Cardiac sympathetic activity ↓
↓ Cardiac parasympathetic activity ↑




↓ Exercise tolerance ↑
↑ Mortality rate ↓
BrS: Baroreflex sensitivity; EF: Ejection fraction; LV: Left ventricular; PE: 
Physical exercise; SERCA2: sarcoplasmic reticulum Ca2+-ATPase; PICs: 
Proinflammatory cytokines.
Heart Failure
Heart failure (HF) is a complex clinical condition that occurs in 
response to ventricular dysfunction due to structural and func-
tional alterations in the heart, which lead to decreased capacity 
of the heart to pump blood to itself and to the periphery5,6,86. To 
counteract such alterations, in an attempt to regulate CO, neurohu-
moral compensatory mechanisms (e.g., the sympathetic nervous 
system [SNS]) are increased during HF87. Although, initially, this 
phenomenon seems advantageous, chronic activation of the SNS 
has a toxic effect on the organic system of HF patients87.
In this sense, in order to study the relation between hyper-
adrenergic activity and HF, α2A/α 2C adrenergic receptor (AR) 
knockout (KO) mice was developed by mating two heterozygous 
C57B16 mice: a α2A-ARKO and a α2c-ARKO
88. During the first 
months of life (1st to 4th month), these animals present no evident 
signals of HF, although muscular and cardiac abnormalities may 
be observed in this period88.
In fact, exercise intolerance, pulmonary edema associated with 
ventricular dysfunction (e.g., lower fractional shortening), and 
cardiac remodeling (e.g., cardiac hypertrophy) are significantly 
highlighted from the 5th month of life89,90,91. The development of 
HF reaches the peak during the 7th month when it is proposed 
that these animals developed a severe HF phenotype91,92,93. In 
addition to the high mortality rate found in α2A/α 2CaARKO mice, 
the animals present rest tachycardia and increased plasma NA 
levels due to increased adrenergic activity92,93,94,95.
Cardinal manifestations in HF patients involve limited muscu-
lar and cardiac functioning, leading the patient to poor prognosis6. 
Regarding muscular functioning, skeletal myopathy consists of 
intrinsic alterations in skeletal muscle observed during HF, which 
are indicated to be responsible for exercise intolerance and early 
fatigue96,97. This condition is one of the main features present 
in cardiac cachexia syndrome and is strongly associated with 
poor outcomes96. In addition to the alterations in skeletal muscle 
structure and function, skeletal myopathy is associated with a 
shift toward fast twitch fibers, oxidative stress, local and systemic 
inflammatory state (i.e., elevated TNF-α), and muscle metabolic 
dysfunction (i.e., mitochondrial respiration, energy transfer system 
and pH regulation) in response  to  stress93,96,98,99,100,101.
This phenotype is not well established in 3-month old 
α2A/α  2CaARKO mice
90,92,102. However, from the 5th month of life, 
these animals present suggestible muscle profile of skeletal 
myopathy due to decreased motor performance (i.e., Rotard 
test), increased oxidative stress (i.e., lipid hydroperoxidation 
and protein carbonylation), gastrocnemius capillary rarefaction, 
muscle atrophy of type I and type II fibers and, due to all these 
factors, exercise intolerance89,91,93,95,101,102.
Catabolic (i.e., ubiquitin-proteasome system [UPS]) and ana-
bolic muscle pathways (i.e., insulin growth factor-1 [IGF- 1]) are 
not exclusively associate with muscle mass homeostasis during 
aging and stroke57, to name a few, but also seem to be present in 
skeletal myopathy of HF93,101. Observations in α2A/α  2CaARKO mice 
with established congestive HF (i.e., 7 months of age) showed that 
these animals present decreased IGF-1 protein content, and phos-
phorylated AKTSer473, 4E-BP1Thr37/46, p70S6KThr389 and GSK3βSer9 
protein content, as well as increased 26S proteasome activity, in 
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soleus muscle93. Moreover, evidences allow to infer that cata-
bolic pathways are activate by oxidative stress and inflammatory 
state99,101. Besides muscular functioning disorders, several levels 
of alterations — functional and structural — are observed in the 
heart of HF patients. In relation to cardiac function, is knowledge 
that HF associated with hyperadrenergic activity is followed by 
calcium (Ca2+) cardiac  kinetics impairment.
It is important to mention that Ca2+ has a crucial role in car-
diac excitation-contraction coupling (ECC), since this molecule 
regulates muscle contraction acting as a critical intermediary 
between the electrical stimulus and the coupling of actin. Here, it 
is described an overview of this phenomenon, while more detailed 
and extensive reviews were performed by several authors103,104,105.
Initially, to generate cardiac systole, the action potential 
propagates trough the membrane of the cardiomyocyte leading 
to its depolarization (from ~ – 90mV to ~+20mV) and, conse-
quently, opening of the voltage-gated sodium (Na+) channels, 
mainly Nay1.5, allowing Na
+ influx103,105. The crescent increase 
on ion Na+ concentration alters the membrane voltage, until 
reaching the threshold to the opening of the L-type voltage-
gated Ca2+ channels — in this case, Cav1.2
105. Subsequent to 
the increase in cytosolic Ca2+ bioavailability (~10-fold), the 
ryanodine receptors 2 (RyR2) — the predominant subtype of 
RyR in the cardiac sarcoplasmic reticulum (SR) — are activated 
by a Ca2+-dependent mechanism, leading to Ca2+ release in the 
junctional zone — a space between cardiac sarcollema and SR 
—, which, subsequently, migrates to the cytosol, binding in its 
site on the troponin C, allowing for muscle contraction through 
actin-myosin interaction103,104,105. During cardiac diastole, a 
decrease in Ca2+ bioavailability is necessary to cause cardiac 
muscle relaxation104,105. This process is dependent on proteins 
involved in transsarcolemmal flux and sarcoplasmic reuptake of 
Ca2+103,105. Regarding transsarcolemmal flux, Na+/Ca2+ exchanger 
(NCX) is one of the main cellular mechanisms responsible for 
the clearance of Ca2+ in the cardiomyocyte103. NCX is located in 
the cardiac cell membrane and — through the electrochemical 
gradient — exchanges one Ca2+ ion to the extracellular milieu 
at the same time that uptakes three Na+ ions103,105. The sarco/
endoplasmic reticulum Ca2+-ATPase protein 2a, henceforth de-
nominated as SERCA2a, is another important cardiac structure 
with key role in calcium handling103. During cardiac systole, 
SERCA2a remains inhibited by dephosphorylated phosphol-
amban (PLN)103,105. However, after its phosphorylation by PKA 
and Ca2+/calmodulin-dependent protein kinase (CaMKII), PLN 
allows SERCA to sequester Ca2+ from cytosol, contributing to 
cardiac relaxation103,104,105. It is important to mention that other 
structures, such as plasma membrane Ca2+ ATPase (PMCA) 
and the mitochondrial uniporter seem to contribute, in a lower 
magnitude, to Ca2+ clearance during cardiac diastole103.
The failing heart is characterized by marked contractile 
(i.e., systolic and diastolic) dysfunction and high prevalence 
of arrhythmias, which has been considered, at least in part, as 
a result of decreased SR Ca2+ handling104,105,106. In fact, in vitro 
experiments with human HF cardiac cells demonstrated smaller 
amplitude of Ca2+ transient, followed by lower SR Ca2+ content 
and load, as well as slow decline of Ca2+ during action potential 
depolarizing in comparison with healthy hearts107.
Moreover, detailed analysis adds data to the aforementioned 
and mentions several other alterations on cardiac Ca2+ transient, 
such as decreased Ca2+ sequestration during cardiac diastole, 
decreased SR Ca2+ stores during cardiac systole, elevated Ca2+ 
availability during cardiac diastole and elevated SR Ca2+ leak 
— which is the inappropriate Ca2+ release during diastole104,105. 
Interestingly, authors have suggested the key role of SERCA2a 
and RyR2 in this phenotype104,105.
Regarding cardiac SERCA2a, experiments have demonstrated 
a decrease of 57% on its activity in HF hearts107. This phenom-
enon seems to be strongly associated with decreased cardiac Ca2+ 
uptake during diastole, concomitantly with increased inhibition 
on PLN104. In turn, in the experiment of AI et al.106, the authors 
observed decreased RyR2 mRNA and protein expression in the 
LV of HF rabbits106. However, during chronic hyperadrenergic 
state, which is present in HF, activation of cardiac β-receptors 
leads to decrease on calstabin 2 and increase on PKA phosphory-
lation at Ser 2808 causing “leaky” of RyR2 and, consequently, 
diastolic SR Ca2+ leak104.
SERCA2a, NCX and SERCA2a/NCX are decreased by 26% 
and 34%, respectively, in the heart of α2A/α 2CaARKO mice
92,94. 
Concomitantly, it is possible to observe increase on NCX94. In rela-
tion to RyR2, its expression is not changed in α2A/α  2CaARKO mice
92.
Due to several compensatory stimuli, including hyperad-
renergic activity, HF patients may present cardiac remodeling, 
which involves the combination of several mechanisms. Cardiac 
hypertrophy is the major pathophysiological response to stress 
in HF. Initially, the hypertrophic response is beneficial, since it 
minimizes parietal stress and maintains contractile performance. 
However, over time, this response becomes harmful, aggravating 
HF. Nevertheless, such response is usually related to detrimental 
changes in the components of extracellular matrix, reduced 
myocardial vascularization, and fibrosis87,108,109.
Cardiac fibrosis is caused by excessive accumulation of 
collagen in the heart during pathological remodeling. As a 
result of fibrosis, electrical conduction is impaired and the risk 
of arrhythmias is increased110,111. The development of fibrosis 
alters the normal operation of the extracellular matrix and may 
lead to systolic and diastolic dysfunctions. The fibrotic tissue 
also contains myofibroblasts with contractile properties, par-
ticipating in the collagen regulation. In response to paracrine 
and autocrine components, such as circulating hormones, me-
chanic stress, and proinflammatory cytokines, and segregation 
of fibrillar collagen precursors, as well as signaling molecules 
responsible for the interaction between parenchymal cells 
and  extracellular matrix111.
Another mechanism involved in cardiac remodeling is oxida-
tive stress, which may impair the contractile function — through 
changes in the proteins that participate in the excitation-con-
traction coupling — and activate signaling kinases hypertrophy, 
activate matrix metalloproteinases, and trigger apoptosis112. 
In this sense, cardiomyocyte apoptosis mechanism has been 
considered fundamental in the progress of HF. The apoptotic 
rate occurring in HF is small; however, this phenomenon has a 
larger influence on myocardial structure and function. Apoptosis 
begins by activation of caspases (cysteinyl-aspartate-directed 
proteases), which cleave vital substrates causing cell death. 
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Caspase substrates in the heart comprise, for example, troponin, 
tropomyosin, α-actin, and myosin chains113.
Apoptosis may occur by the extrinsic or intrinsic pathways. 
Briefly, in the extrinsic pathway, a death binder (such as FasL or 
TNF-α) activates a death receptor, triggering the death-inducing 
signaling complex, activating caspase-8, which, in turn, acti-
vates caspase-3, causing apoptosis. In the intrinsic pathway, 
mitochondria are essential to mediate the apoptotic process. 
The mitochondria release cytochrome c into the cytosol, causing 
the formation of an activation complex — the apoptosome — 
containing apoptotic protein activating factor-1 and caspase-9, 
leading to activation of other caspases, such  as caspase-3114.
In 5–7-month old α2A/α 2CaARKO mice, it is possible to ob-
serve increased heart height, LV mass, cardiomyocyte width and 
CSA, as well as cardiac fibrosis and collagen volume, suggesting 
a phenotype generally observed in remodeled hearths89,91,94,95,102. In 
the study of Pereira et al.90, quantitative morphometric analyses 
indicated that cardiomyocyte width and cardiac collagen were, 
respectively, 28% and 55% increased in α2A/α 2CaARKO mice 
in comparison with age-matched control90.
Nevertheless, the failing heart of α2A/α 2CaARKO mice show, 
associated with structural alterations, decreased fractional 
shortening (FS) and increased LV dilation linked to increased 
left ventricular end-systolic dimension (LVSED) and left ven-
tricular end-diastolic dimension (LVEDD), characterizing LV 
dysfunction phenotype89,94,95,102.
The effects and mechanisms of PE on HF: evidence 
from α2A/α 2CARKO
Physical inactivity contributes to the progression of HF, whereas 
PE has been widely recommended as a non-pharmacological 
therapy capable of counteracting the deleterious effects of HF 
on the organic system4,97,109.
Evidence have demonstrate the effectiveness of moderate 
intensity PE (i.e., 60% of the maximal workload, 1 hour per day, 
5 days per week, for 8 weeks) to increase exercise tolerance in 
α2A/α 2CaARKO mice to levels similar to those observed in age-
matched WT90,93,94,95,96,97,101. Of interest, PE does not seem to act 
just by reversing the deleterious effects of HF in muscle func-
tioning in the established pathology, but evidence has indicated 
its action in preventing the development of such effects92,102.
In fact, in the experiments of Medeiros et al.92,115, low-
to-moderate swimming trained 3-month old α2A/α 2CaARKO 
mice (5 days per week, 60 minutes per day, during 8 weeks) 
presented preserved exercise tolerance during the development 
of HF, in comparison with age-matched control92,111. Moreover, 
it is important to mention that inhibition of the development 
of exercise intolerance seems to be an adaptation exclusively 
in response to PE since data have demonstrated that treatment 
with β-blocker — carvedilol — did not alter exercise tolerance 
in α2A/α 2CaARKO mice
102.
Such improvements in exercise tolerance after PE are prob-
ably associated with changes in the catabolic profile present 
in α2A/α 2CaARKO, such as capillary rarefaction
93,102 . Recently, 
in the experiment of Bacurau et al.93, HF mice submitted to 
low-to-moderate aerobic exercise presented elevated exer-
cise tolerance and motor performance, as well as attenuated 
soleus muscle mass atrophy in comparison with age-matched 
control93. Authors also demonstrated that attenuated muscular 
atrophy could be associated with changes on regulating muscle 
mass pathways, since PE elevated the protein content of the 
anabolic arm (i.e., IGF-1, PI3K, phosphorylated AKTSer473, 
4E-BP1Thr37/46, p70S6KThr389) and decreased the catabolic arm 
(i.e., proteasome activity)93.
Functional and structural parameters in α2A/α 2C ARKO also 
seem to be responsive to PE109. In fact, experiments have demon-
strated the effectiveness of PE to lead to decreased Ca2+ decay, 
concomitantly with the peak of Ca2+ transient increase in the 
cardiomyocytes of α2A/α 2CaARKO
95. PE increases the balance 
between Ca2+ reuptake by SERCA2a and Ca2+ clearance by 
NCX92. These alterations on Ca2+ after PE are associated with 
improvement on cardiac function91,95.
Regarding molecular mechanisms, PE increases SERCA2a 
and SERCA2A/NCX ratio toward control group levels92,94. This 
phenomenon is an isolated product of increase on SERCA2a since 
NCX levels are found decreased in the heart of α2A/α 2CaARKO 
mice92,94. Furthermore, it is possible to observe an increase in 
the phosphorylation of PLN at Ser16 and Thr17 after PE92,94,95.
Therefore, considered together, these data indicate that PE 
leads to significant phosphorylation of PLN at Ser16 and Trh17 
removing its inhibitory effect on SERCA2a, thus contributing 
to enhanced Ca2+ transient observed in trained animals95.
In turn, morphological alterations generally observed in 
remodeled hearts are impaired in trained α2A/α 2C ARKO, since 
heart weight, cardiomyocyte width, LV mass, collagen content 
and cardiomyocyte CSA are decreased in these animals in com-
parison with sedentary age-matched control89,95. Considering 
these data it is possible to indicate that PE has an anti-remodeling 
effect on the heart of α2A/α 2C ARKO mice
89.
Moreover, some studies have aimed to describe the 
mechanisms associated with the anti-remodeling effect of 
PE. Experiments demonstrated that PE is capable of trigger-
ing significant decrease on the translocation to the nucleus of 
elements strongly associated with cardiac remodeling, such as 
calcineurin and its downstream targets — NFATe3 and GATA-4 
— in the heart of α2A/α 2C ARKO
89. It is important mention that, 
in the heart of sedentary mice, both results were increased and 
associated with elevated β-MHC expression, suggesting a key 
role of this pathway in cardiac hypertrophy89. However, other 
factors indirectly associated with cardiac remodeling (i.e., RAS 
system) also demonstrated responsiveness to PE, since ANGII 
and ACE activity were decreased, while ACE2 expression was 
increased, after PE90.
Such post-PE improvements on cardiac Ca2+ handling, remodel-
ing, and skeletal myopathy occur in conjunction with improving 
FS in α2A/α 2C ARKO to levels similar to those observed in control 
non-KO mice89,91,95,102. As in skeletal myopathy, data indicate that 
PE can also act as a preventive tool, since 3-month old animals — 
without evident signals of HR — submitted to swimming exercise 
demonstrated preserved FS in comparison with sedentary mice92.
Table 3 shows a summary of the physiopathological ele-
ments present in α2A/α 2CaARKO, as well as the effects of PE.
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Conclusions
In conclusion, when the ethical principles of animal experimenta-
tion are considered, the use of animals in Physical Education as 
a field of knowledge has gained great prominence, particularly 
in understanding the pathophysiological mechanisms of CVD 
and the effects of PE on parameters that are unquantifiable in 
humans. Moreover, considering the data observed in this review, 
it is possible to infer that animal models of CVD seem to be an 
efficient and reliable tool to study the mechanisms responsible 
for the effects of PE on CVD.
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